Bepotastine besilate: A novel anti-histamine
Oral bepotastine is a nonsedative second-generation antihistamine with an action on other inflammatory mediators. It also acts as a mast cell stabilizer and leukotrienes inhibitor. Its distribution in the brain is very limited. We explored the currently available literature on bepotastine besilate t...
Main Authors: | Kiran Godse, Neeti Kumari |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2017-01-01
|
Series: | Indian Journal of Drugs in Dermatology |
Subjects: | |
Online Access: | http://www.ijdd.in/article.asp?issn=2455-3972;year=2017;volume=3;issue=2;spage=64;epage=68;aulast=Godse |
Similar Items
-
Bepotastine besilate ophthalmic solution 1.5% for alleviating nasal symptoms in patients with allergic conjunctivitis
by: Cavet ME, et al.
Published: (2018-03-01) -
Comparative analysis of safety and efficacy of Alcaftadine 0.25%, Olopatadine hydrochloride 0.2% and Bepotastine besilate 1.5% in allergic conjunctivitis
by: Shruti Ayyappanavar, et al.
Published: (2021-01-01) -
Observer-masked trial comparing efficacy of topical olopatadine (0.1%), bepotastine (1.5%), and alcaftadine (0.25%) in mild to moderate allergic conjunctivitis
by: Lakshey Dudeja, et al.
Published: (2019-01-01) -
Knowledge and attitude of medical resident doctors toward antihistamines
by: Esha Chainani, et al.
Published: (2015-01-01) -
The role and choice criteria of antihistamines in allergy management – expert opinion
by: Piotr Kuna, et al.
Published: (2016-12-01)